Table 2.
Phase and Components | Specific Activities |
---|---|
Preintervention phase: Sep 2015-Mar 2017 | |
Quantitative data collection | Baseline surveys (practice survey, practice member survey) |
Intervention phase: Dec 2015-Nov 2017 | |
Quantitative data collection: Dec 2015-Nov 2017a | Quarterly ABS reports |
Qualitative data collection: Jul 2016-Apr 2017 | Interviews with 80 study participants:
|
Postintervention phase: Nov 2016-Apr 2018 | |
Quantitative data collection: Nov 2016-Dec 2017 | Postintervention surveys (practice survey, practice member survey) |
Qualitative data collection: Sep 2017-Aug 2018 | Interviews with 74 facilitators:
|
Analysis phase: Mar 2020-Dec 2021 | |
Quantitative data analyses | Analyses of descriptive data from 162 facilitators (158 external, 4 internal) |
Qualitative data analyses | Analyses based on interviews with 36 of 87 facilitators interviewed:
|
ABS = aspirin use for high-risk patients, blood pressure control, smoking cessation counseling.
The active interventions ranged in duration from 3 to 18 months.